Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Defined CBD for Sleep Physiology in Insomnia
NCT05233761Phase 2Completed
- Start
- Feb 2022
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Insomnia comparing Defined CBD with Placebo (2 arms). Primary endpoint: Percentage of Time Spent in the Combination of Slow Wave Sleep (SWS) and Rapid Eye Movement (REM) Sleep at 4 weeks. Started Feb 2022; status: completed.
02
Drugs
cannabidiol
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT05233761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05233761.